<DOC>
	<DOCNO>NCT00362947</DOCNO>
	<brief_summary>The optimal treatment superficial venous thrombosis ( SVT ) still uncertain . Though low molecular weight heparin ( LMWH ) consider treatment choice , study conduct far give clear indication optimal dose duration treatment . This study aim evaluate whether intermediate therapeutic dose LMWH ( parnaparin ) effective prophylactic dose also assess whether 10 rather 30 day sufficient treatment .</brief_summary>
	<brief_title>Different Doses Duration Low Molecular Weight Heparin ( Parnaparin ) Superficial Vein Thrombosis</brief_title>
	<detailed_description>Outpatients episode SVT grand saphenous vein ( least 4 cm ) , and/or SVT small saphenous vein ( least 4 cm ) , and/or SVT collateral vein large saphenous vein thigh ( least 4cm ) include prospective , randomise , double blind , national multicentre study . Patients randomise double-blind group receive ( syrinx identical appearance ) consecutively numbered box : A - Parnaparin , dose 8,500 IU aXa take subcutaneously day 10 day B - Parnaparin , dose 8,500 IU aXa per day 10 day follow Parnaparin 6,400 IU aXa per day subsequent three week . C - Parnaparin , dose 4,250 IU aXa per day 30 day Elastic compression treatment recommend special stock and/or elastic bandaging compression ankles 20-40 mmHg , contraindicate .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Thrombophlebitis</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Weight &gt; 50 kg less 110 kg SVT grand saphenous vein least 4 cm SVT small saphenous vein least 4 cm Collateral SVT large saphenous vein thigh least 4cm SVT grand saphenous vein reach saphenofemoral cross ( within 3 cm ) SVT small saphenous vein reach saphenopopliteal cross Documented proximal distal DVT pulmonary embolism SVT secondary sclerotherapy Pregnancy puerperium uncontrolled arterial hypertension ( Systolic pressure &gt; 180 mmHg diastolic pressure &gt; 110 mmHg ) Active peptic ulcer Bacterial endocarditis Stroke previous 3 month Haemorrhagic diathesis Thrombocytopenia ( platelet &lt; 100,000/ µL ) Hypersensitivity heparin history thrombocytopenia induce heparin Creatinine &gt; 2 mg % ( &gt; 180 µmol/L ) Heparin therapy ( dose ) anticoagulant therapy longer previous 72 hour Inhospital development SVT Previous saphenectomy method Surgery previous 30 day Serious liver disease Use dextran , mannitol , thrombolytic treatment , chronic use NSAID cortisonebased drug . Active cancer chemotherapy radiotherapy Thrombectomy superficial vein involve Refusal give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Superficial vein thrombosis</keyword>
	<keyword>thrombophlebitis</keyword>
	<keyword>LMWH</keyword>
	<keyword>parnaparin</keyword>
</DOC>